已选(0)清除
条数/页: 排序方式:
|
| Papillary Thyroid Micro Carcinoma: The Incidence of High-Risk Features and Its Prognostic Implications 期刊论文 FRONTIERS IN ENDOCRINOLOGY, 2019, 卷号: 10 作者: Gao, Rui; Jia, Xi; Liang, Yiqian; Fan, Kun; Wang, Xiaoxiao 收藏  |  浏览/下载:34/0  |  提交时间:2019/11/19
|
| Combination of 131I-anti-endoglin monoclonal antibody and 5-fluorouracil may be a promising combined-modality radioimmunotherapy strategy for the treatment of hepatocellular carcinoma 期刊论文 Biotechnology and Biotechnological Equipment, 2018, 页码: 1-8 作者: Duan C.; Li Y.; Yang W.; Zhang C. 收藏  |  浏览/下载:7/0  |  提交时间:2019/12/11
|
| The analysis of bone metabolism in hospitalized patients with Graves disease and the changes after 131I therapy 期刊论文 Fudan University Journal of Medical Sciences, 2017, 卷号: 44, 期号: 2, 页码: 186-191 作者: Ma W.-J.; Lyu C.-Y.; Zhang Y.; Xu G.-P.; He S.-M. 收藏  |  浏览/下载:4/0  |  提交时间:2019/12/11
|
| 2015年美国甲状腺学会《成人甲状腺结节与分化型甲状腺癌诊治指南》解读:分化型甲状腺癌131I治疗新进展 期刊论文 2016, 卷号: 26, 期号: 1, 页码: 1-12 作者: 林岩松; 李娇 收藏  |  浏览/下载:2/0  |  提交时间:2020/01/04
|
| In Patients With Low- to Intermediate-Risk Thyroid Cancer, a Preablative Thyrotropin Level of 30 μIU/mL Is Not Adequate to Achieve Better Response to 131I Therapy 期刊论文 2016, 卷号: 41, 期号: 6, 页码: 454-8 作者: Zhao Teng; Liang Jun; Guo Zhenqing; Li Tianjun; Lin Yansong 收藏  |  浏览/下载:2/0  |  提交时间:2020/01/04 |
| Thyroid Cancer: Radiation Safety Precautions in 131I Therapy Based on Actual Biokinetic Measurements. 期刊论文 Radiology, 2014, 卷号: Vol.273 No.1, 页码: 211-219 作者: Liu B; Peng W; Huang R; Tian R; Zeng Y 收藏  |  浏览/下载:7/0  |  提交时间:2019/03/01 |
| A comparative study of influential factors correlating with early and late hypothyroidism after I-131 therapy for Graves' disease 期刊论文 Chinese medical journal, 2010, 卷号: 123, 期号: 12, 页码: 1528-1532 作者: WANG; Ren-fei; TAN; Jian; ZHANG 收藏  |  浏览/下载:4/0  |  提交时间:2019/12/04
|
| 碘-131标记重组人肿瘤坏死因子-α治疗荷人肝癌裸鼠的实验研究 学位论文 : 四川大学, 2008 作者: 龙亚红 收藏  |  浏览/下载:5/0  |  提交时间:2019/04/19
|